TY - JOUR
T1 - Structure-related pharmacokinetics of xanthines after direct administration into the peritoneal cavity of rats
AU - Kuzuya, Takafumi
AU - Hasegawa, Takaaki
AU - Shiraki, Rika
AU - Nabeshima, Toshitaka
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1997
Y1 - 1997
N2 - The pharmacokinetic characteristics, peritoneal permeability and hydrophobicity of three xanthine derivatives, theophylline, enprofylline and 1-methyl-3-propylxanthine (MPX), were investigated in rats. Isotonic saline (30 ml) containing xanthine (2.5, 5 and 10 mg/kg) and blue dextran (0.2%) was administered intraperitoneally. The pharmacokinetic parameters of these xanthines were estimated using concentration-time data obtained from the peritoneal cavity and systemic circulation. Disappearance of these xanthines from the peritoneum declined in almost a monoexponential manner regardless of the dose administered. The volume of distribution (33.9 ml) in the peritoneal cavity was similar to the injection volume, indicating that dialysate was not diluted by the fluid in the peritoneal cavity and the effect of drug adsorption on the peritoneal membrane was minimal. The pharmacokinetics of MPX was dose-dependent, but that of theophylline and enprofylline was not. The fraction of the administered dose absorbed through the peritoneal cavity was 0.71, 0.85, 0.93 for theophylline, enprofylline and MPX, respectively. The peritoneal clearance was significantly different (p < 0.05) among the three xanthines by two-way analysis of variance, and a strong correlation was noted between their peritoneal clearance and hydrophobicity (r = 0.98, p < 0.01). These findings suggest that hydrophobicity is an important determinant in the peritoneal permeation of these xanthines.
AB - The pharmacokinetic characteristics, peritoneal permeability and hydrophobicity of three xanthine derivatives, theophylline, enprofylline and 1-methyl-3-propylxanthine (MPX), were investigated in rats. Isotonic saline (30 ml) containing xanthine (2.5, 5 and 10 mg/kg) and blue dextran (0.2%) was administered intraperitoneally. The pharmacokinetic parameters of these xanthines were estimated using concentration-time data obtained from the peritoneal cavity and systemic circulation. Disappearance of these xanthines from the peritoneum declined in almost a monoexponential manner regardless of the dose administered. The volume of distribution (33.9 ml) in the peritoneal cavity was similar to the injection volume, indicating that dialysate was not diluted by the fluid in the peritoneal cavity and the effect of drug adsorption on the peritoneal membrane was minimal. The pharmacokinetics of MPX was dose-dependent, but that of theophylline and enprofylline was not. The fraction of the administered dose absorbed through the peritoneal cavity was 0.71, 0.85, 0.93 for theophylline, enprofylline and MPX, respectively. The peritoneal clearance was significantly different (p < 0.05) among the three xanthines by two-way analysis of variance, and a strong correlation was noted between their peritoneal clearance and hydrophobicity (r = 0.98, p < 0.01). These findings suggest that hydrophobicity is an important determinant in the peritoneal permeation of these xanthines.
UR - http://www.scopus.com/inward/record.url?scp=0030710522&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030710522&partnerID=8YFLogxK
U2 - 10.1248/bpb.20.1051
DO - 10.1248/bpb.20.1051
M3 - Article
C2 - 9353563
AN - SCOPUS:0030710522
SN - 0918-6158
VL - 20
SP - 1051
EP - 1055
JO - Biological and Pharmaceutical Bulletin
JF - Biological and Pharmaceutical Bulletin
IS - 10
ER -